GB8523338D0 - Treatment of obesity - Google Patents
Treatment of obesityInfo
- Publication number
- GB8523338D0 GB8523338D0 GB858523338A GB8523338A GB8523338D0 GB 8523338 D0 GB8523338 D0 GB 8523338D0 GB 858523338 A GB858523338 A GB 858523338A GB 8523338 A GB8523338 A GB 8523338A GB 8523338 D0 GB8523338 D0 GB 8523338D0
- Authority
- GB
- United Kingdom
- Prior art keywords
- diet
- tryptophan
- daily
- composition
- amount
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000008589 Obesity Diseases 0.000 title abstract 3
- 235000020824 obesity Nutrition 0.000 title abstract 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 8
- 230000037213 diet Effects 0.000 abstract 5
- 235000005911 diet Nutrition 0.000 abstract 5
- 229960004799 tryptophan Drugs 0.000 abstract 4
- 239000000463 material Substances 0.000 abstract 2
- 206010033307 Overweight Diseases 0.000 abstract 1
- 239000002830 appetite depressant Substances 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
- A61K31/405—Indole-alkanecarboxylic acids; Derivatives thereof, e.g. tryptophan, indomethacin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/30—Dietetic or nutritional methods, e.g. for losing weight
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Abstract
Treatment of obesity, especially in man. In the invention an overweight patient is given a daily diet in which the amount of proteinaceous material is restricted below the patient's normal average daily intake of protein, together with a daily dose of at least about 0.5 grams of L-tryptophan as appetite-suppressant. Thus, the invention provides a composition for use in the treatment of obesity. That composition comprises L-tryptophan and a protein-restricted diet composition as carrier, the amount of L-tryptophan in the composition being such as to provide at least about 0.5 grams of L-tryptophan per daily amount of diet. Preferably, the carrier is a protein-restricted formula diet, the diet comprising on a daily amount basis less than about 100 grams of proteinaceaous material and an energy level of no more than about 1000 Kcals.
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858523338A GB8523338D0 (en) | 1985-09-20 | 1985-09-20 | Treatment of obesity |
PCT/GB1986/000560 WO1987001590A1 (en) | 1985-09-20 | 1986-09-19 | A composition and pack for use in the treatment of obesity |
EP86905379A EP0238533A1 (en) | 1985-09-20 | 1986-09-19 | A composition and pack for use in the treatment of obesity |
GB08622618A GB2180747A (en) | 1985-09-20 | 1986-09-19 | Tryptophan composition for treatment of obesity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB858523338A GB8523338D0 (en) | 1985-09-20 | 1985-09-20 | Treatment of obesity |
Publications (1)
Publication Number | Publication Date |
---|---|
GB8523338D0 true GB8523338D0 (en) | 1985-10-23 |
Family
ID=10585524
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB858523338A Pending GB8523338D0 (en) | 1985-09-20 | 1985-09-20 | Treatment of obesity |
GB08622618A Withdrawn GB2180747A (en) | 1985-09-20 | 1986-09-19 | Tryptophan composition for treatment of obesity |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08622618A Withdrawn GB2180747A (en) | 1985-09-20 | 1986-09-19 | Tryptophan composition for treatment of obesity |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP0238533A1 (en) |
GB (2) | GB8523338D0 (en) |
WO (1) | WO1987001590A1 (en) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2648044A1 (en) * | 1989-06-07 | 1990-12-14 | Norchim | Liquid pharmaceutical composition exhibiting anorexigenic activity |
FR2657013B1 (en) * | 1990-01-18 | 1992-05-15 | Medgenix Group Sa | DIETETIC COMPOSITION BASED ON POLYPEPTIDES AND AMINO ACIDS. |
ES2087027B1 (en) * | 1994-08-03 | 1997-02-01 | Univ Illes Balears | NUTRITIONAL THERMOGENETIC SUPPLEMENTS, FOODS THAT CONTAIN THEM AND APPLICATIONS. |
GB9416921D0 (en) * | 1994-08-22 | 1994-10-12 | Conway Gitta C | A nutritional preparation |
US6013622A (en) * | 1998-04-15 | 2000-01-11 | Nutriceutical Technology Corporation | Method of regulating appetite and metabolism |
AU3525299A (en) * | 1998-04-23 | 1999-11-16 | Pro Dietic Rdp (S.A.R.L.) | Protein supplement, food composition containing same, preparation method and use |
FR2777751B1 (en) * | 1998-04-23 | 2001-11-02 | Pro Dietic Rdp | PROTEIN SUPPLEMENT, FOOD COMPOSITION CONTAINING THE SAME, PROCESS FOR THEIR PREPARATION AND THEIR USE. |
US6132724A (en) * | 1998-04-29 | 2000-10-17 | City Of Hope National Medical Center | Allelic polygene diagnosis of reward deficiency syndrome and treatment |
DK0951842T3 (en) | 1999-01-20 | 2003-01-06 | Nutricia Nv | Nutritional product for an infant |
PT1153548E (en) | 2000-05-12 | 2007-08-08 | Nattopharma Asa | Vitamin k2 containing food product |
GB0220182D0 (en) | 2002-08-30 | 2002-10-09 | Cardiovascular Res Inst Maastr | Organic compounds |
ATE477812T1 (en) * | 2003-02-07 | 2010-09-15 | Campina Bv | USE OF TRYPTOPHAN-RICH PEPTIDES FROM WHEY PROTEIN HYDROLYSATES TO TREAT OVERWEIGHT AND OBESITY |
ITTO20070391A1 (en) * | 2007-06-05 | 2008-12-06 | Medestea Res & Production S P | COMPOSITION OF FOOD SUPPLEMENT, DRUG OR MEDICAL DEVICE AND ITS USE TO SUPPRESS THE APPETITE, IMPROVING TONE AND HUMOR, WITH NATURAL ANTIDEPRESSIVE ACTIVITY AND ANTI-STASTENIC EFFECT |
EP3518688A1 (en) * | 2016-09-29 | 2019-08-07 | Société des Produits Nestlé S.A. | Methods that reduce food cravings, promote weight loss, and/or treat overweight or obesity |
CN114631629A (en) * | 2020-12-15 | 2022-06-17 | 中国科学院上海营养与健康研究所 | A method for treating obesity with low protein content |
Family Cites Families (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3150044A (en) * | 1962-04-18 | 1964-09-22 | Sam I Stein | Treatment and composition for high blood pressure and palpitation |
GB1289096A (en) * | 1968-10-03 | 1972-09-13 | ||
US3809752A (en) * | 1971-03-24 | 1974-05-07 | W Fishman | Anti-obesity process |
DE2305209A1 (en) * | 1972-02-14 | 1973-08-23 | Hoffmann La Roche | PHARMACEUTICAL PREPARATION |
GB1356370A (en) * | 1972-03-06 | 1974-06-12 | Howard A N | Methods and formulations for the treatment of obesity |
US4298601A (en) * | 1972-03-06 | 1981-11-03 | Technutra, S.A. | Method and formulations for the treatment of obesity |
US4042687A (en) * | 1975-11-24 | 1977-08-16 | Control Drug, Inc. | Method of treating obesity by the oral administration of a predigested protein composition |
US4210637A (en) * | 1978-07-31 | 1980-07-01 | Massachusetts Institute Of Technology | Composition and method for suppressing appetite for calories as carbohydrates |
US4377595A (en) * | 1979-08-13 | 1983-03-22 | Massachusetts Institute Of Technology | Process for reducing depression |
DK198583A (en) * | 1982-05-20 | 1983-11-21 | Showa Denko Kk | PIG FEED |
GB2129299A (en) * | 1982-11-09 | 1984-05-16 | Alec James Coppen | Pharmaceutical compositions |
CH658165A5 (en) * | 1984-01-04 | 1986-10-31 | Nestle Sa | FOOD PRODUCT EFFECTIVE IN THE TREATMENT OF LEPROSY. |
-
1985
- 1985-09-20 GB GB858523338A patent/GB8523338D0/en active Pending
-
1986
- 1986-09-19 GB GB08622618A patent/GB2180747A/en not_active Withdrawn
- 1986-09-19 EP EP86905379A patent/EP0238533A1/en active Pending
- 1986-09-19 WO PCT/GB1986/000560 patent/WO1987001590A1/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
GB8622618D0 (en) | 1986-10-22 |
GB2180747A (en) | 1987-04-08 |
WO1987001590A1 (en) | 1987-03-26 |
EP0238533A1 (en) | 1987-09-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB8622618D0 (en) | Treatment of obesity | |
NZ334635A (en) | Treatment of autoimmune diseases such as rheumatoid arthritis with a vaccine | |
FI970747A (en) | Combination product for use in immunological diseases | |
AU678795B2 (en) | Application of riluzole in the treatment of neurological lesions related to traumatic injuries | |
GR3036901T3 (en) | Treatment of partial growth hormone insensitivity syndrome | |
NZ504026A (en) | Methods for treating hypercoagulable states or acquired protein C deficiency using human-activated protein C | |
EP0342956A3 (en) | Use of phytic acid or its salts for the treatment of hyperlipemia, obesity and obesity-related diseases | |
EA200000506A1 (en) | COMPOSITION TO REDUCE WEIGHT | |
PL325865A1 (en) | Selective antagonists of beta3-adrenergic receptor | |
NZ230155A (en) | N-2,3-butadienyl-n"-substituted-triamindalkanes and alkenes, and pharmaceutical compositions | |
GR3032041T3 (en) | Idebenone compositions for treating Alzheimer's disease. | |
GR3003750T3 (en) | ||
EP0167995A3 (en) | (pyrrol-1-yl)-phenyl-dihydropyridazinones, their preparation and use | |
JPS57126420A (en) | Drug for digestive organ | |
EP0264953A3 (en) | Amino acid preparations containing n,n'-bis-l-amino acid-l-cystin peptides for oral and parenteral use | |
EP0946174A4 (en) | Treatment of urinary incontinence and compositions for use therein | |
GB9617611D0 (en) | Treatment of autoimmune disease | |
BG49742A1 (en) | Affrodisiance means | |
UA10249A (en) | Method for treating diabetic angiopathy | |
GR950100380A (en) | Natural ointment for pharmaceutical and cosmetical use | |
UA10764A (en) | Method for treating diabetes mellitus and its vascular complications in patients exposed to ionizing radiation | |
UA19610A (en) | Method for treatment of opisthorchiasis invasion | |
PT82535B (en) | Pharmacologically active propionylanilides | |
UA10248A (en) | Method for treating ischemic heart disease in the setting of diabetes mellitus | |
IT1261863B (en) | Oral pharmaceutical preparations based on controlled delayed release of diltiazem, with which it is possible to use only one daily administration |